| RS2147448071 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147448137 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147448164 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS2147448284 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS2147448673 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2147448693 |
MEGF8
|
Health Risk |
Pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS2147452502 |
TSPAN7
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 58 |
| RS2147452753 |
GRIN2D
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS2147453642 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2147455888 |
GRIN2D
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS2147455922 |
GRIN2D
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS2147456007 |
MBTPS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147456067 |
OPHN1
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147457199 |
OPHN1
|
Health Risk |
Pathogenic |
— |
| RS2147457839 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147462360 |
OPHN1
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2147463824 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2147463929 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2147465256 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS2147468376 |
PQBP1
|
Health Risk |
Pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS2147468543 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS2147470500 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147470514 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147470742 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2147470791 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147471075 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147471207 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147471723 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147471760 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147471863 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147471872 |
PQBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2147471929 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147471979 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147472050 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147472132 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147472136 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147472174 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2147472395 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147472456 |
PQBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS2147472458 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147472674 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147472734 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147472907 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147472959 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147473129 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147473202 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 3B, Duchenne muscular dystrophy |
| RS2147473301 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147473404 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147473470 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147473623 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147473703 |
HNF1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Renal cysts and diabetes syndrome |
| RS2147473858 |
HNF1B
|
Health Risk |
Likely pathogenic |
— |
| RS2147474151 |
HNF1B
|
Health Risk |
Likely pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS2147474434 |
PQBP1
|
Health Risk |
Pathogenic |
— |
| RS2147475435 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 46 |
| RS2147475642 |
PQBP1
|
Health Risk |
Pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS2147475773 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Nonpapillary renal cell carcinoma |
| RS2147475916 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147476101 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147476203 |
GLA
|
Health Risk |
Likely pathogenic |
— |
| RS2147476253 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147476255 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147477318 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Cardiovascular phenotype |
| RS2147477422 |
GLA
|
Health Risk |
Pathogenic |
Nephrotic syndrome, Fabry disease |
| RS2147477583 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147477618 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS2147477659 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147477791 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147477845 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147480438 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147480442 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147480502 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147480697 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147480882 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147480960 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147481894 |
OPHN1
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147481899 |
OPHN1
|
Health Risk |
Pathogenic |
— |
| RS2147484573 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS2147485040 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS2147485081 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
PCDH19-related epilepsy, Developmental and epileptic encephalopathy |
| RS2147486180 |
SLC35A2
|
Health Risk |
Likely pathogenic |
non-lesional focal epilepsy, non-lesional focal epilepsy |
| RS2147486594 |
SLC35A2
|
Health Risk |
Likely pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147486684 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147486766 |
SLC35A2
|
Health Risk |
Likely pathogenic |
non-lesional focal epilepsy, non-lesional focal epilepsy |
| RS2147487028 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147487148 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS2147487234 |
SLC35A2
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC35A2-congenital disorder of glycosylation, SLC35A2-related disorder |
| RS2147487247 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147487313 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147487375 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147487622 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147487659 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147487830 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS2147487910 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS2147487930 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS2147489491 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147489558 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147489679 |
SLC35A2
|
Health Risk |
Likely pathogenic |
non-lesional focal epilepsy, non-lesional focal epilepsy |
| RS2147489736 |
SLC35A2
|
Health Risk |
Pathogenic |
SLC35A2-congenital disorder of glycosylation, SLC35A2-congenital disorder of glycosylation |
| RS2147492627 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |